Project documents | Atezolizumab with chemotherapy for neoadjuvant treatment of resectable early or locally advanced invasive triple-negative breast cancer [ID1574] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 194 KB)

Published:

05 February 2021
Final stakeholder list (PDF 201 KB)

Published:

05 February 2021
Draft scope and provisional stakeholder list comments table (post-referral) (PDF 213 KB)

Published:

05 February 2021
Equality impact assessment (Scoping) (PDF 122 KB)

Published:

05 February 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope pre referral (PDF 206 KB)

Published:

22 October 2020
Draft matrix post referral (PDF 201 KB)

Published:

22 October 2020